• 5571 Citations
  • 21 Scopus h-Index
20082020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2019

Biomarkers of hyperprogression and pseudoprogression with immune checkpoint inhibitor therapy

Failing, J. J., Dudek, O. A., Marin Acevedo, J. A., Chirila, R. M., Dong, H. M., Markovic, S. N. & Dronca, R. S., Aug 1 2019, In : Future Oncology. 15, 22, p. 2645-2656 12 p.

Research output: Contribution to journalReview article

1 Scopus citations

Immune Checkpoint Inhibitor Toxicities

Marin-Acevedo, J. A., Chirila, R. M. & Dronca, R. S., Jul 1 2019, In : Mayo Clinic proceedings. 94, 7, p. 1321-1329 9 p.

Research output: Contribution to journalReview article

Open Access
8 Scopus citations

Paradox-driven adventures in the development of cancer immunology and immunotherapy

Barham, W., Gicobi, J. K., Yan, Y., Dronca, R. S. & Dong, H. M., Jan 1 2019, (Accepted/In press) In : Genes and Diseases.

Research output: Contribution to journalReview article

Open Access
2018

Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy

Yan, Y., Kumar, A. B., Finnes, H., Markovic, S. N., Park, S., Dronca, R. S. & Dong, H., 2018, In : Frontiers in immunology. 9, 1 p., 1739.

Research output: Contribution to journalReview article

Open Access
42 Scopus citations
2014

Immunomodulatory effects of sex hormones: Requirements for pregnancy and relevance in melanoma

Enninga, E. A. L., Holtan, S. G., Creedon, D. J., Dronca, R. S., Nevala, W. K., Ognjanovic, S. & Markovic, S. N., Apr 2014, In : Mayo Clinic proceedings. 89, 4, p. 520-535 16 p.

Research output: Contribution to journalReview article

28 Scopus citations

Latest advances in chemotherapeutic, targeted, and immune approaches in the treatment of metastatic melanoma

Shah, D. J. & Dronca, R. S., Apr 2014, In : Mayo Clinic proceedings. 89, 4, p. 504-519 16 p.

Research output: Contribution to journalReview article

56 Scopus citations

Rare presentations of primary melanoma and special populations: A systematic review

Kottschade, L. A., Grotz, T. E., Dronca, R. S., Salomao, D. R., Pulido, J. S., Wasif, N., Jakub, J. W., Bagaria, S. P., Kumar, R., Kaur, J. S., Morita, S. Y., Moran, S. L., Nguyen, J. T., Nguyen, E. C., Hand, J. L., Erickson, L. A., Brewer, J. D., Baum, C. L., Miller, R. C., Swanson, D. L. & 2 others, Lowe, V. & Markovic, S. N., Dec 11 2014, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 37, 6, p. 635-641 7 p.

Research output: Contribution to journalReview article

9 Scopus citations
2011

The dynamic human immune response to cancer: It might just be rocket science

Holtan, S. G., Dronca, R. S., Nevala, W. K., Porrata, L. F., Mansfield, A. S., Block, M. S., Leontovich, A. A., Grotz, T. E., Turner, J. D., Frisch, H. P. & Markovic, S. N., Sep 1 2011, In : Immunotherapy. 3, 9, p. 1021-1024 4 p.

Research output: Contribution to journalReview article

8 Scopus citations
2008

VTE and mortality associated with erythropoiesis-stimulating agents in cancer-associated anemia

Dronca, R. S. & Steensma, D. P., Jul 24 2008, In : Nature Clinical Practice Oncology. 5, 9, p. 504-505 2 p.

Research output: Contribution to journalReview article

4 Scopus citations